Ultra Low-Coverage Whole-Genome Sequencing as an Alternative to Genotyping Arrays in Genome-Wide Association Studies
2022 · Frontiers in Genetics · 34 citations
https://doi.org/10.3389/fgene.2021.790445
R
Robert Ferguson
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
66
Papers
492
Citations
9
h-index
9
i10-index
Robert Ferguson is an academic researcher from Eastern Cooperative Oncology Group. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immunotherapy and Immune Responses & Melanoma and MAPK Pathways. The author has an h-index of 9, co-authored 57 publications.
ORCID: 0000-0002-5752-2956Papers by this author
worksImmunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts
2018 · Journal of Translational Medicine · 28 citations
https://doi.org/10.1186/s12967-017-1352-z
Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanoma
2025 · Nature Medicine · 7 citations
https://doi.org/10.1038/s41591-025-03699-3
Germline genetic host factors as predictive biomarkers in immuno-oncology
2019 · Immuno-Oncology Technology · 6 citations
https://doi.org/10.1016/j.iotech.2019.08.001
Immunomodulatory germline variation associated with the development of multiple primary melanoma (MPM)
2019 · Scientific Reports · 5 citations
https://doi.org/10.1038/s41598-019-46665-z
Tumor immunogenomic signatures improve a prognostic model of melanoma survival
2021 · Journal of Translational Medicine · 5 citations
https://doi.org/10.1186/s12967-021-02738-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat